GUBBA PHARMA IN E NEWS

Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma

September 8, 2021 Gubba Pharma In E News

Pharma major Dr Reddy’s Laboratories Ltd has entered into a definitive agreement with Citius Pharmaceuticals Inc for the sale of its entire right of investigational...

Continue Reading

Hetero Pharma Receives EUA from DCGI for Tocilizumab Production

September 8, 2021 Gubba Pharma In E News

Hetero, a globally renowned vertically integrated pharmaceutical organisation announced that the Drug Controller General of India (DCGI) has issued Emergency Use Authorisation (EUA) for the...

Continue Reading

Costly active pharma ingredients from China create healthcare hurdles in India

September 8, 2021 Gubba Pharma In E News

A steep 50 per cent rise in the prices of active pharmaceutical ingredients (API) has raised doubts on the shortage of essential drugs required to...

Continue Reading

India needs to diversify pharma raw material imports, up R&D spends: RBI paper

September 1, 2021 Gubba Pharma In E News

The Covid-19 pandemic has been a “stress test” for the Indian pharma industry, and exposed its high dependence on imported raw materials and “surprisingly low”...

Continue Reading

Rs. 500 crore MoU signed for API unit in Himachal Pradesh

September 1, 2021 Gubba Pharma In E News

A Memorandum of Understanding (MoU) was signed between the State Government and M/s Concord Biotech Ltd. in presence of Chief Minister Jai Ram Thakur for...

Continue Reading

42 FDA Officers honoured on 15th August 2021: Independence Day

September 1, 2021 Gubba Pharma In E News

42 Officers of Food and Drugs Administration (FDA) from different States of India have been honored on 15th August 2021 during Independence Day celebration in...

Continue Reading

Nutanix India registers 24% growth in Q3, onboards NKGSB, Aurobindo Pharma as clients

August 25, 2021 Gubba Pharma In E News

US-headquartered Nutanix’s Indian arm registered a 24% year-on-year growth in customer acquisition and 21% in partner acquisition during Q3 (February-April) of fiscal 2021. The cloud...

Continue Reading

Needle-free system to administer Zydus Cadila’s ZyCoV-D vaccine

August 25, 2021 Gubba Pharma In E News

Zydus Cadila’s ZyCoV-D, is the first Covid-19 vaccine built on a DNA platform, to have received an Emergency Use Authorisation by a regulator. Significantly, the...

Continue Reading

China’s Port Shutdown Raises Fears of Closures Worldwide

August 25, 2021 Gubba Pharma In E News

A COVID outbreak that has partially shut one of the world’s busiest container ports is heightening concerns that the rapid spread of the delta variant...

Continue Reading